Sign In
Buy AVDL
$21.64
+0 (+0%)
At Close: May 08, 2026
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
10:29am, Friday, 07'th Oct 2022 Benzinga
Gainers
Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
Atlis Motor Vehicles, Inc. (NASDAQ: AMV) climbed 95.5% to close at $24.49.
InVivo Therapeutics H
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday
06:58am, Friday, 07'th Oct 2022 Benzinga
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session.
Tilray Brands, Inc. (NASDAQ: TLRY)
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
05:53am, Monday, 19'th Sep 2022 Benzinga
Gainers
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares climbed 50.4% to settle at $3.76 on Friday after
Avadel's LUMRYZ: A Good Night's Sleep For Narcolepsy Patients
08:30am, Tuesday, 06'th Sep 2022
Avadel Pharmaceuticals' LUMRYZ (FT218), with its essential once daily dosing, has snagged a tentative approval from the FDA. Once finally approved, LUMRYZ has serious prospects for knocking off Jazz's
Avadel Pharmaceuticals: Navigating Through The Uncertainty
06:11am, Monday, 05'th Sep 2022
Avadel Pharmaceuticals goes into the spotlight today. This small biopharma company recently got 'tentative' FDA approval for its flagship drug but is still waiting on one patent challenge to move forw
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022
02:11pm, Wednesday, 10'th Aug 2022 Benzinga
Upgrades
According to Stifel, the prior rating for V2X Inc (NYSE:VVX) was changed from Hold to Buy. The current stock performance of V2X shows a 52-week-high of $33.69 and a 52-week-low of $29.55. Mo
What 5 Analyst Ratings Have To Say About Avadel Pharmaceuticals
01:13pm, Wednesday, 10'th Aug 2022 Benzinga
Analysts have provided the following ratings for Avadel Pharmaceuticals (NASDAQ:AVDL) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
1
Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q2 2022 Results - Earnings Call Transcript
05:44pm, Tuesday, 09'th Aug 2022
Avadel Pharmaceuticals plc (NASDAQ:AVDL ) Q2 2022 Earnings Conference Call August 9, 2022 8:00 AM ET Company Participants Brandi Robinson - Senior Vice President of Corporate Affairs Gregory Divis - C
Wall Street Analysts Think Avadel (AVDL) Could Surge 106%: Read This Before Placing a Bet
01:55pm, Friday, 05'th Aug 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 105.6% in Avadel (AVDL). While the effectiveness of this highly sought-after metric is questionable, the positi
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9
12:00pm, Tuesday, 02'nd Aug 2022 GlobeNewswire Inc.
DUBLIN, Ireland, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that i
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9
08:00am, Tuesday, 02'nd Aug 2022
DUBLIN, Ireland, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it
Avadel Pharmaceuticals Announces Tentative Approval of LUMRYZ™ (sodium oxybate) extended-release oral suspension
11:00am, Tuesday, 19'th Jul 2022 GlobeNewswire Inc.
- Validates the safety profile and clinical efficacy of LUMRYZ
Why Is SCWorx Jumping By Around 36%? 20 Stocks Moving In Wednesday's Pre-Market Session
11:05am, Wednesday, 06'th Jul 2022 Benzinga
Gainers
Hexo Corp (NYSE: HEXO) rose 106.8% to $0.43 in pre-market trading. HEXO’s shareholders, on Tuesday, approved the note transaction with Tilray Brands.
SCWorx Corp. (NASDAQ: WORX) rose 35.5%
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
09:21am, Wednesday, 06'th Jul 2022 Benzinga
Gainers
Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Rubicon Technology, Inc. (NASDAQ: RBCN) shares surged 66.1% to settle at $15.05 on Tuesday after the c
Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session
04:05pm, Tuesday, 05'th Jul 2022 Benzinga
Gainers
Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.
Rubicon Technology, Inc. (
